Clinical Trial Update: Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating NKT cell infusion for advanced solid tumors, with indications including non-small cell lung cancer and gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• NKT cell infusion

Snippet

Sponsor: Minghui Zhang | Conditions: Non-small Cell Lung Cancer, Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN